ENDO: Once-Weekly Basal Insulin Fc Promising for T2DM

TUESDAY, March 23, 2021 -- For individuals with type 2 diabetes mellitus (T2DM), once-weekly, long-acting, basal insulin Fc (BIF) is noninferior to insulin degludec for glycemic control, according to a study presented at the annual meeting of The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news